Asset Dedication, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2024. The put-call ratio across all filers is 55.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Asset Dedication, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q2 2024$4,457
+111325.0%
1,2310.0%0.00%
Q1 2024$4
-33.3%
1,2310.0%0.00%
Q4 2023$6
-14.3%
1,231
-5.2%
0.00%
-100.0%
Q3 2023$7
-12.5%
1,2980.0%0.00%0.0%
Q2 2023$8
-27.3%
1,298
+5.4%
0.00%0.0%
Q1 2023$11
+22.2%
1,2310.0%0.00%0.0%
Q4 2022$9
-99.9%
1,2310.0%0.00%0.0%
Q3 2022$8,000
-20.0%
1,2310.0%0.00%0.0%
Q2 2022$10,000
-41.2%
1,2310.0%0.00%
-50.0%
Q1 2022$17,000
-51.4%
1,2310.0%0.00%
-50.0%
Q4 2021$35,000
-16.7%
1,2310.0%0.00%
-33.3%
Q3 2021$42,000
-17.6%
1,2310.0%0.01%
-25.0%
Q2 2021$51,000
+410.0%
1,231
+435.2%
0.01%
+300.0%
Q1 2021$10,000
-52.4%
230
-34.3%
0.00%
-50.0%
Q4 2020$21,000
+23.5%
3500.0%0.00%0.0%
Q3 2020$17,000
+142.9%
350
+125.8%
0.00%
+100.0%
Q2 2020$7,0001550.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2024
NameSharesValueWeighting ↓
Matrix Capital Management Company, LP 17,332,191$535,565,00013.21%
TIGER MANAGEMENT L.L.C. 1,115,411$34,466,00013.06%
VIKING GLOBAL INVESTORS LP 38,406,607$1,186,764,0006.18%
Senator Investment Group LP 5,113,085$146,145,0003.67%
Casdin Capital, LLC 463,125$14,310,562,0001.48%
Graticule Asia Macro Advisors LLC 356,326$11,010,0000.86%
Ratan Capital Management LP 41,272$1,275,0000.67%
Rock Springs Capital Management LP 545,000$16,841,0000.67%
MYDA Advisors LLC 34,000$1,051,0000.48%
Aristotle Atlantic Partners, LLC 50,459$1,559,0000.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders